Head-To-Head Analysis: AdaptHealth (NASDAQ:AHCO) vs. Avivagen (OTCMKTS:VIVXF)

Avivagen (OTCMKTS:VIVXF) and AdaptHealth (NASDAQ:AHCO) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability.

Valuation & Earnings

This table compares Avivagen and AdaptHealth”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avivagen	N/A	N/A	N/A	($0.04)	N/A
AdaptHealth	$3.26 billion	0.44	$90.42 million	$0.55	19.39

AdaptHealth has higher revenue and earnings than Avivagen. Avivagen is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Avivagen and AdaptHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avivagen	N/A	N/A	N/A
AdaptHealth	2.53%	4.85%	1.75%

Analyst Ratings

This is a summary of recent ratings and target prices for Avivagen and AdaptHealth, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avivagen	0	0	0	0	0.00
AdaptHealth	0	2	5	0	2.71

AdaptHealth has a consensus price target of $13.60, indicating a potential upside of 27.52%. Given AdaptHealth’s stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Avivagen.

Institutional & Insider Ownership

82.7% of AdaptHealth shares are owned by institutional investors. 2.1% of Avivagen shares are owned by insiders. Comparatively, 1.6% of AdaptHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

AdaptHealth beats Avivagen on 9 of the 10 factors compared between the two stocks.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.